Gut microbiota and cardiovascular disease
M Witkowski, TL Weeks, SL Hazen - Circulation research, 2020 - Am Heart Assoc
Fecal microbial community changes are associated with numerous disease states, including
cardiovascular disease (CVD). However, such data are merely associative. A causal …
cardiovascular disease (CVD). However, such data are merely associative. A causal …
[HTML][HTML] Dietary lipids, gut microbiota and lipid metabolism
M Schoeler, R Caesar - Reviews in endocrine and metabolic disorders, 2019 - Springer
The gut microbiota is a central regulator of host metabolism. The composition and function of
the gut microbiota is dynamic and affected by diet properties such as the amount and …
the gut microbiota is dynamic and affected by diet properties such as the amount and …
[HTML][HTML] The cross-talk between gut microbiota and lungs in common lung diseases
D Zhang, S Li, N Wang, HY Tan, Z Zhang… - Frontiers in …, 2020 - frontiersin.org
Emerging findings indicate there is a vital cross-talk between gut microbiota and the lungs,
which is known as gut–lung axis. The gut disturbances in lung diseases including allergy …
which is known as gut–lung axis. The gut disturbances in lung diseases including allergy …
Dietary metabolism, the gut microbiome, and heart failure
Advances in our understanding of how the gut microbiota contributes to human health and
diseases have expanded our insight into how microbial composition and function affect the …
diseases have expanded our insight into how microbial composition and function affect the …
[HTML][HTML] Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target
Trimethylamine N-oxide (TMAO) is a molecule generated from choline, betaine, and
carnitine via gut microbial metabolism. The plasma level of TMAO is determined by several …
carnitine via gut microbial metabolism. The plasma level of TMAO is determined by several …
[HTML][HTML] Trimethylamine N-oxide (TMAO) in human health
P Gatarek, J Kaluzna-Czaplinska - EXCLI journal, 2021 - ncbi.nlm.nih.gov
Due to numerous links between trimethylamine-N-oxide (TMAO) and various disorders and
diseases, this topic is very popular and is often taken up by researchers. TMAO is a low …
diseases, this topic is very popular and is often taken up by researchers. TMAO is a low …
[HTML][HTML] The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
M Trøseid, GØ Andersen, K Broch, JR Hov - EBioMedicine, 2020 - thelancet.com
Host-microbiota interactions involving inflammatory and metabolic pathways have been
linked to the pathogenesis of multiple immune-mediated diseases and metabolic conditions …
linked to the pathogenesis of multiple immune-mediated diseases and metabolic conditions …
Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review
WHW Tang, F Bäckhed, U Landmesser… - Journal of the American …, 2019 - jacc.org
Despite major strides in reducing cardiovascular disease (CVD) burden with modification of
classic CVD risk factors, significant residual risks remain. Recent discoveries that linked …
classic CVD risk factors, significant residual risks remain. Recent discoveries that linked …
[HTML][HTML] Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk
Normal platelet function is critical to blood hemostasis and maintenance of a closed
circulatory system. Heightened platelet reactivity, however, is associated with …
circulatory system. Heightened platelet reactivity, however, is associated with …
[HTML][HTML] Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis
Summary Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite,
both enhances atherosclerosis in animal models and is associated with cardiovascular risks …
both enhances atherosclerosis in animal models and is associated with cardiovascular risks …